Skip to main content


Corporate Responsibility


According to the Centre for ADHD Awareness, Canada (CADDAC), Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent neurodevelopmental disorder observed in childhood, occurring in one-in-20 school-aged children. It also occurs globally in four per cent of adults – yet people living with ADHD continue to experience stigma due to a general misunderstanding of the condition, and ADHD patient groups report that access to diagnosis and treatment remain an obstacle to many. Despite these challenges, recent years have brought encouraging improvements in public understanding and awareness of the condition, and many people with ADHD are living highly productive lives while managing their condition.

At Purdue Pharma (Canada) we are passionate about improving the lives of people living with ADHD. For more than 10 years in Canada, the company has conducted research and development in the field of ADHD.

To hallmark ADHD Awareness Month this October, the company has launched a Canada-wide survey to explore attitudes and knowledge related to the condition. Looking at the results, it is encouraging to see that awareness of ADHD is growing, with 83 per cent of Canadian respondents knowing that adults, not just children, can be diagnosed with the condition.[i]

However, there is still a long way to go. For example, our poll found that one quarter of Canadians surveyed were not sure whether people diagnosed with ADHD eventually outgrow the condition. In fact, 60 per cent of children remain affected by the symptoms of ADHD well into adulthood.

Of notable concern regarding stigma, almost half (44 per cent) of Canadians mistakenly identified ADHD as a mental illness, when in reality it is a neurodevelopmental disorder.

By sharing this information we hope to engage Canadians in an ongoing conversation to help minimize the stigma and misperceptions of ADHD; shed light on the importance of a timely, accurate medical diagnosis; and support a multidisciplinary approach to managing the condition. Further, we are committed to educating health care professionals on appropriate prescribing of all ADHD treatments and overall management of the condition.

We at Purdue Pharma (Canada) are proud to be a part of the vibrant and thriving ADHD community, and look forward to continuing to help people with ADHD live healthy and productive lives.



[i] The Purdue Pharma (Canada) 2017 ADHD Awareness Month poll was conducted via national online survey of n=1362 Canadians between June 23 –July 4, 2017 (an associated margin of error for a randomly selected sample of this size would be ±2.7%, 19 times out of 20).

Latest News

Doing the right thing

Purdue Pharma (Canada) believes that our corporate responsibility does not stop with providing innovative medicines designed to improve patient health and well-being. We believe we have a larger role to play in the health of our communities and we’re proud of our long standing commitment to corporate citizenship and community service. As part of our corporate responsibility program, we have four areas of focus:

  • Sponsorships, donations and grants

    Purdue Pharma (Canada) takes an active role in supporting organizations that try to improve the quality of life where our employees live and work. We provide sponsorships, donations, in-kind service support and grants.

    Our Commitment to the Community

    Purdue Pharma (Canada) believes its responsibility goes beyond the provision of innovative medicines.  Each year we contribute funding to a wide range of community organizations across Canada. These include health and science education programs, disease awareness initiatives, community agencies as well as the scientific and academic communities.

    As a proud and active member of Canada’s INNOVATIVE MEDICINES CANADA, Purdue Pharma (Canada) supports the Guidelines for Transparency in Stakeholder Funding. Please click here for a list of groups to which the company has provided funding.


    Purdue Pharma (Canada) is proud to donate products for international humanitarian aid through Health Partners International of Canada (HPIC).  This agency arranges shipments of products to needed areas of the world and also supplies physician travel packs, containing medicines and medical supplies suitable for use by individual physicians on overseas aid missions.

    If you are a physician interested in product donations to support international medical missions, please contact HPIC directly at 1-800-627-1787 or


    As an active member of Innovative Medicines Canada, Purdue Pharma (Canada) joins other member companies in voluntarily publishing aggregated sums of payments made to Canadian Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs) to increase transparency about our operations in Canada. Innovative Medicines Canada built a reporting framework to ensure consistency in the approach. As a key stakeholder within the Canadian healthcare system, the pharmaceutical industry plays an important role with patients, caregivers, healthcare practitioners (HCPs), governments, as well as payers in Canada.

    By bringing greater transparency to these valuable and well-regulated relationships we hope to increase understanding of the research-based pharmaceutical industry’s collaboration across the healthcare sector, and contribute to enhancing trust and value for patients, as well as our healthcare system.

    Collaboration among HCPs, HCOs and the pharmaceutical industry is essential to improving the quality of life of Canadians as it drives scientific advancements, enhances medical education, and promotes health literacy.

    View Purdue Pharma (Canada)’s disclosure of 2016 payments.

  • Preventing the diversion and abuse of prescription drugs

    The under-treatment of pain and the misuse, abuse and diversion of prescription pain medications are both serious public health problems. Pain affects millions of people each year. Pain medications remain a safe and effective treatment for appropriately selected and monitored patients. Unfortunately, misuse and abuse and diversion of pain medications can lead to tragic consequences, including addiction, overdose and death. Purdue Pharma (Canada) has been committed to providing resources to support the responsible use of prescription opioids for pain.

    As a pharmaceutical leader in pain medicine, we are acutely aware of the public health risk these powerful medications create, especially when they are diverted, misused and/or abused. That’s why we work with health experts and government agencies on efforts to reduce the risk of opioid abuse and misuse without reducing appropriate pain treatment. At Purdue Pharma (Canada) we support a number of initiatives that address the misuse, abuse and diversion of prescription drugs.

    Learn more

  • Safe disposal of prescription medicine

    Purdue has been an industry advocate of proper storage and safe disposal of prescription medicine. Safe disposal keeps drugs out of the hands of children and other people who might use them inappropriately. It keeps drugs out of landfill sites and water supplies. And it prevents the inadvertent use of unused or expired medications. A proud member of Canada Health Products Stewardship Association (CHPSA), Purdue helps to fund nation-wide programs that ensure safe and effective collection and disposal of prescription medications. Please visit for more information.


    Don’t throw it out, visit

  • Employee initiatives

    Purdue Pharma (Canada) employees can expect a work environment that focuses on their health and wellness, while providing opportunities to grow, learn, be engaged and fulfilled.Employees also have the opportunity to give back through volunteer efforts in the community and various fundraising campaigns, such as United Way.

    Each year Purdue Pharma (Canada) employees join together to donate their time, energy and financial resources during our annual employee fundraising campaign for the United Way of Ajax-Pickering-Uxbridge.  Our longstanding commitment to United Way has been recognized year after year with several awards.  In 2009, Purdue Pharma (Canada) celebrated an outstanding campaign with two awards, including a corporate and employee award of excellence honouring the generosity of our company and employees and an award recognizing our employee campaign coordinator for running a successful campaign.

    We also run annual campaigns where employees donate clothes, personal care and household items to Durham-area shelters to help those in need.

    These initiatives help foster a culture of volunteerism where employees have the opportunity to get involved and make a difference.

    For more information on our Corporate Responsibility initiatives, contact us at 905-420-6400.

Background Image

Keeping healthcare professionals informed

Purdue Pharma (Canada) works in partnership with key stakeholders to ensure appropriate prescribing, dispensing and use of our medicines. This includes continuing health education (CHE) for healthcare professionals.

Our educational efforts include:

  • Our Pain Management Resource Centre (PMRC), which offers an annual program independently developed and taught by doctors focusing on pain assessment, addiction and abuse, and proper prescribing of controlled substances.
  • Distributing medical practice guidelines and screening tools that have been developed by independent experts and relevant authorities to help doctors identify people who are seeking medicines illegally.
  • Supporting activities of major professional societies at their annual conferences, including seminars, speaker presentations and satellite symposia.
  • Grants to hospitals and other organizations for grand rounds, speaker presentations and workshops at the local, provincial and national levels.

These programs help to educate thousands of healthcare professionals in Canada.

For more information please contact our CHE team at 905-420-6400.